baber/WOPTO huggingface dataset:
Patent DK-2621277-T3 (DK)
Inventor: WALTER HARALD
IPC: A01P3/00
Filed: 2011-09-28
Granted: 2018-03-12
Abstract: A method of controlling phytopathogenic diseases on useful plants or on propagation material thereof, which comprises applying to the useful plants, the locus thereof or propagation material thereof a combination of components (A) and (B) in a synergistically effective amount, wherein component (A) is a compound of formula I compound of formula I wherein R is hydrogen or methoxy; Q is R1 is hydrogen, halogen or C1-C6alkyl; R2 is hydrogen, halogen, C1-C6alkyl, C2-C6alkenyl, C3-C6alkinyl, C3-C6cycloalkyl-C3-C6alkinyl, halophenoxy, halophenyl-C3-C6alkinyl, C(C1-C4alkyl)═NO—C1-C4alkyl, C1-C6haloalkyl, C1-C6haloalkoxy, C2-C6haloalkenyl, or C2-C6haloalkenyloxy; R3 is hydrogen, halogen, C1-C6alkyl; R4, R5 and R6, independently from each other, are hydrogen, halogen or -≡—R7; with the proviso that at least one of R4, R5 and R6 is different from hydrogen; R7 is hydrogen, C1-C6alkyl, C1-C6haloalkyl or C1-C4alkoxyalkyl; and R8 is hydrogen or methoxy; and agrochemically acceptable salts/isomers/structural isomers/stereoisomers/diastereoisomers/enantiomers/tautomers and N-oxides of those compounds; and component (B) is a compound selected from compounds known for their fungicidal and/or insecticidal activity, is particularly effective in controlling or preventing fungal diseases of useful plants.
Patent DK-2686335-T3 (DK)
Inventor: BLECK GREGORY THOMAS
IPC: C12P21/02
Filed: 2012-03-13
Granted: 2018-07-30
Abstract: The present invention relates to improved decorin compositions and methods of their production.
Patent DK-2825212-T3 (DK)
Inventor: ROVISON JOHN M
IPC: A61L101/20
Filed: 2013-03-12
Granted: 2018-03-26
Abstract: A method of sterilizing a material, said method comprising the steps of: a) providing a sterilizing composition comprising (i) peracetic acid and (ii) a stabilizer selected from the group consisting of citric acid, isocitric acid, aconitic acid and propane-1,2,3-tricarboxylic acid; b) introducing such sterilizing composition into a hot gaseous stream to produce a peracetic acid vapor; and c) contacting such peracetic acid vapor with the material to be sterilized. The use of such an organic acid stabilizer results in an unexpected reduction in the amount of residue deposited on the heating surface employed to vaporize the sterilizing composition.
Patent DK-2932968-T3 (DK)
Inventor: FANG WENKUI K
IPC: A61P9/12
Filed: 2009-06-05
Granted: 2018-03-12
Abstract: Described herein are compounds for use in a method of treating a condition or disease in a subject by administering to the subject a pharmaceutical composition containing an effective amount of an ±-adrenergic modulator. The compounds are also useful for alleviating types of pain, both acute and chronic.
Patent DK-0402649-T3 (DK)
Inventor: MCCLURE GARY W
IPC: B23K37/053
Filed: 1990-05-17
Granted: 1994-02-28
Abstract: This invention relates to a bolt-type boiler wall tube tool in which boiler tubes in the form of a wall can be clampingly secured to retain adjacent ends of the boiler tubes forming the wall in aligned relation when connecting the ends of the boiler wall tubes by welding.
Patent DK-0401623-T3 (DK)
Inventor: PETERSEN UWE DR
IPC: C07D471/04
Filed: 1990-05-26
Granted: 2000-07-17
Abstract: The present invention relates to a process for the preparation of 7-(3-amino- and 3-aminomethyl-1-pyrrolidinyl)-3-quinolonecarboxylic acids and -naphthyridonecarboxylic acids of the general formula I 
<IMAGE>
 in which X<1>, R<1>-R<6>, m, n and A have the meaning given in the description, which have been disclosed as antibacterial agents and are prepared by reaction of 7-halo-3-quinolonecarboxylic acids or -naphthyridonecarboxylic acids with 3-aminopyrrolidine or 3-aminomethylpyrrolidine in free form or in the form of the 3-acylamino- or 3-acylaminomethyl-pyrrolidines and subsequent removal of the acyl radicals. 
<??>The invention additionally relates to compounds of the formulae III and IV 
<IMAGE>
 in which the substituents have the meaning given in the description, and to the use of IV as medicaments and for the production of medicaments.
Patent DK-0450251-T3 (DK)
Inventor: MAITRE BRUNO PIERRE
IPC: B60C11/03
Filed: 1990-12-18
Granted: 1996-09-23
Abstract: A tire tread of elastomeric material formed into ground engaging elements (1) is provided with sipes (2) in said elements. The sipes are in the form of incisions. A first incision portion(s) extends inwardly from the tread surface and then splits into at least two incision portions (3,4) which continue to extend away from the tread surface while at the same time diverging apart from one another.
Patent DK-0448940-T3 (DK)
Inventor: BORGHI ANGELO
IPC: A23K20/195
Filed: 1991-02-07
Granted: 1997-11-03
Abstract: Process for preparing mannosyl teicoplanin derivatives comprising a microbiological transformation of de-mannosyl teicopolanin compounds with a culture of Actinoplane teichomyceticus ATCC 31121, and a new mannosyl teicoplanin aglycone.
Patent DK-0520053-T3 (DK)
Inventor: PENMAN DAVID GERARD DR
IPC: A61B5/145
Filed: 1992-01-09
Granted: 1996-04-01
Abstract: PCT No. PCT/GB92/00049 Sec. 371 Date Oct. 13, 1992 Sec. 102(e) Date Oct. 13, 1992 PCT Filed Jan. 2, 1992 PCT Pub. No. WO91/18549 PCT Pub. Date Dec. 12, 1991.A pH electrode suitable for in vivo use is provided in a cannula 10, and comprises a reference electrode 14 consisting of a chloridized silver wire surrounded by a solid unbuffered internal reference material 16 comprising potassium chloride, silver chloride, citric acid and sorbitol as a hygroscopic agent. The material 16 is surrounded by a PVC sleeve 12. The tip of the cannula 10 has a pH sensitive polymer-based membrane 20 across its end. The reference material has a pH when hydrated of about 2 which is below the range of pH response of the membrane 20.
Patent DK-0617612-T3 (DK)
Inventor: FAWZI MAHDI B
IPC: A61K47/10
Filed: 1992-11-18
Granted: 1998-04-14
Abstract: A novel solid pharmaceutical dispersion that improves the bioavailability of poorly water soluble drugs is produced by combining the drug with a polymer carrier such as polyvinylpyrrolidone. The drug is combined with the carrier without the need for using organic solvents or melting temperatures (fusion) through the use of a transition compound such as polyethylene glycol which partially solubilizes the drug and/or plasticizes the polymer.
Patent DK-0578152-T3 (DK)
Inventor: JORDAN GUENTHER DIPL-ING
IPC: B02C4/28
Filed: 1993-07-02
Granted: 1998-03-30
Abstract: The structure of the surfaces of the grinding rollers (1) of two-roller machines is important for the drawing-in behaviour of the material to be ground and therefore for throughput and comminution. As the surfaces of the grinding rollers are subject to wear, when abrasive materials are ground in particular, and inhomogeneities in the grinding material can cause the removal (5) of the surfaces of the grinding rollers, assessment of the state of the surfaces, which is carried out visually, is important, but is made difficult by the rapid speed of rotation of the grinding rollers and by frequent adhesion of the ground material, and can therefore only be carried out when the grinding rollers (1) are stationary. It is proposed to carry out measurement of the surface structure in a contactless fashion using an electronic transducer (3) during operation of the two-roller machine, the measuring signal not being affected by non-magnetisable ground material which is adhering to the grinding roller (1). <IMAGE>
Patent DK-0585132-T3 (DK)
Inventor: MARSH MICHAEL JOHN CAMILLE
IPC: G06K19/07
Filed: 1993-08-26
Granted: 1999-06-14
Abstract: The invention relates to an identification system comprising an interrogator and a plurality of transponders. The interrogator includes transmitter means (30) for transmitting an interrogation signal to the transponder, receiver means (10) for receiving a response signal from the transponder, and processor means (18) for identifying the transponder from data in the response signal. Clock extraction means (12, 20, 22, 24, 26) are further provided for extracting a transponder clock signal from the response signal which is used to synchronise the modification of the interrogation signal with the response signal from the transponder. Each transponder comprises receiver means (110, 116) for receiving the interrogation signal, a transponder clock generator (114), a code generator (112), transmitter means (110), and a modulator (118) connected to the code generator, so that on receipt of the interrogation signal the transponder transmits a response signal containing data which identifies the transponder. The interrogator is adapted to detect successful reception of a response signal from any transponder, to derive a synchronisation signal from the response signal of that transponder, and to modify the interrogation signal synchronously with the response signal to indicate successful reception of the response signal. Each transponder further includes means (116) responsive to a respective modification of the interrogation signal to cease transmission of its response signal. <IMAGE>
Patent DK-0613256-T3 (DK)
Inventor: MORRISON GARY
IPC: G01R21/133
Filed: 1993-02-26
Granted: 1999-08-23
Abstract: A system for analogue to digital conversion comprising a means (4) for receiving an input analogue signal, a dither means for adding a dither signal and an analogue to digital converter (2) for converting the combined input signal and dither signal to a digital value, characterised in that the dither means provides a dither signal of a form comprising a first periodic dither signal having superimposed and being shaped by a second signal having at least one component which varies the first periodic dither signal over at least one quantisation interval of the analogue to digital converter. <IMAGE>
Patent DK-0643693-T3 (DK)
Inventor: FREEDMAN JULES
IPC: C07D211/20
Filed: 1993-01-11
Granted: 1999-11-29
Abstract: A compound of formula (1) wherein Ph1, Ph2, and Ph3 are each a phenyl group optionally substituted with a combination of up to three members of the group consisting of fluoro, chloro, bromo, hydroxy, trifluoromethyl, NH2, N(CH3)2, (C1-4)alkyl and (C1-4)alkoxy or the phenyl group can be substituted with a methylenedioxy group; n is an integer of from 1 to 5; m is 0 or an integer of from 1 to 2; and q is an integer of from 1 to 2; or an acid addition salt thereof, which reverse multidrug resistance in multidrug resistant tumor cells and are thus useful adjuvants in the treatment of tumors. These compounds apparently function by inhibiting a p-glycoprotein pump which becomes activated in late stage tumor development and which is inherently present in tumors from certain origins.
Patent DK-0672162-T3 (DK)
Inventor: BRINGI VENKATARAMAN
IPC: C12R1/91
Filed: 1993-02-22
Granted: 2000-12-18
Abstract: The present invention relates to a process for producing taxol and other taxanes in high yields from cell culture of Taxus species comprising: cultivating, in suspension culture in one or more nutrient media, cells derived from callus and/or suspension cultures of Taxus species, and recovering said taxol and other taxanes from said cells and/or said medium of said cell culture.
Patent DK-0659747-T3 (DK)
Inventor: ROGER PIERRE-MARIE-ALBERT
IPC: A61K31/44
Filed: 1994-12-20
Granted: 1999-01-11
Abstract: The invention relates to compounds of formula I <IMAGE> in which R1 to R5 are as defined in Claim 1. These compounds find their application in the treatment of all pathologies involving CRF.
Patent DK-0702683-T3 (DK)
Inventor: ELDER RHODERICK HUGH
IPC: A61K31/52
Filed: 1994-06-08
Granted: 2004-02-02
Abstract: O &cir& _<6>-hetarylalkyl- or naphthylalkylguanine derivatives of formula (I) wherein Y is H, ribosyl, deoxyribosyl, or R"XCHR"', wherein X is O or S, R'' and R''' are alkyl, or substituted derivatives thereof; R' is H, or alkyl or hydroxyalkyl; R is (i) a cyclic group having at least one 5- or 6-membered heterocyclic ring, optionally with a carbocyclic or heterocyclic ring fused thereto, the or each heterocyclic ring having at least one hereto atom chosen from O, N or S, or a substituted derivative thereof; or (ii) naphthyl or a substituted derivative thereof; and pharmaceutically acceptable salts thereof, exhibit the ability to deplete O &cir& _<6>-alkylguanine-DNA alkyltransferase (ATase) activity. A process for preparation of the compounds is described. The compounds have utility in combination with alkylating agents in the chemotherapeutic treatment of tumour cells.
Patent DK-0751779-T3 (DK)
Inventor: LEBL MICHAL
IPC: C07K1/04
Filed: 1994-06-21
Granted: 2002-04-15
Abstract: The present invention is directed to solid phase of the type suitable for solid phase synthesis phase synthesis of a test compound, comprising a linker, the linker comprising a methionine group and an ester group <IMAGE>
Patent DK-0709034-T3 (DK)
Inventor: PRELLA GIOVANNI
IPC: A23C21/06
Filed: 1995-07-07
Granted: 2001-11-26
Abstract: Prodn. of compsns. for improving the texture of dairy prods. comprises preparing a starting material contg. casein and whey proteins in a wt. ratio of 70:30 to 40:60 respectively; adjusting the pH to 6.1-6.7, if necessary, by adding an acidifying agent; heating the mixt. at 70-95 degrees C for 1-15 min. to form a coprecipitate; opt. shearing this; and drying the prod.
Patent DK-0703228-T3 (DK)
Inventor: JONES CHARLES DAVID
IPC: C07C217/18
Filed: 1995-09-18
Granted: 2002-05-21
Abstract: The present invention provides a compound of formula I <CHEM>  wherein R<1> is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R<2> is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl) or -OSO2(C4-C6 alkyl);     n is 2 or 3; and R<3> is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholino, dimethylamino, diethylamino, or 1-hexamethyleneimino;  or a pharmaceutically acceptable salt thereof. The compounds are useful for treating diseases such as post-menopausal syndrome, and uterine fibroid disease, endometriosis, and aortal smooth muscle cell proliferation.
Patent DK-0664184-T3 (DK)
Inventor: PETERS HENRI
IPC: F16C11/06
Filed: 1995-01-03
Granted: 2000-04-03
Abstract: The universal joint with high mechanical resistance, esp. to abrasion, impact and crushing, consists of an inner spherical element (1) in an outer cage (3). The spherical element is made from a very hard steel, pre-treated at 882-1029 N/mm2 in its core and having a surface hardness of 55 HRC to a depth of 1.5 - 3 mm. The cage is forged and machines from an austenitic manganese steel, with an inner diameter slightly greater than that of the spherical element to give it a circumference 1 - 25 mm longer. The cage's inner surface is cold-forged to give a hardness of 38 - 44 HRC to a slight depth - a few tenths of a millimetre, while its core material retains its ductility. The spherical element is fitted into the cage by pressure after the cage has been cut (5) and opened, and then welded (7) after closing. For universal joints of large diameter (300 mm and more) the materials from which the spherical element and cage are made can be reversed.
Patent DK-0714978-T3 (DK)
Inventor: AUBERT DANIEL
IPC: C09K23/14
Filed: 1995-11-17
Granted: 2001-04-23
Abstract: Gel compsns. comprise: (a) a non-polar medium; (b) a liq. "multicaternary surfactant" (disclosed as having at least two hydrophobic chains attached to a hydrophilic head) which is in acid form and is soluble or dispersible in the medium; (c) neutralising agent present in amt. which is 2-30 (pref. 4-20) times the amt. required to neutralise the surfactant; (d) water in amt. of 0.2-5 (pref. 0.3-3) moles per mole of surfactant, at least part of the water being introduced with surfactant and/or neutralising agent; (e) opt. emulsifier capable of emulsifying the gel to aq. medium; and (f) opt. solid filler that is opt. soluble in medium.
Patent DK-0758336-T3 (DK)
Inventor: WOLF RICHARD A
IPC: C07F7/08
Filed: 1995-04-18
Granted: 1999-11-29
Abstract: The present invention relates to a novel process for preparing 1-(3-trialkylsilylphenyl)-2,2,2-trifluoromethyl ethanones which are useful for the treatment of Alzheimer's disease and senile dementia as disclosed by Schirlin, et al. in European Patent Application Publication No. 0 409 676, published Jan. 23, 1991.
Patent DK-0773167-T3 (DK)
Inventor: NAGASHIMA KAZUFUMI
IPC: C23C16/26
Filed: 1995-08-09
Granted: 2003-02-17
Abstract: This apparatus is provided with an outer hollow electrode (12) formed so as to house a container (20) therein and having a hollow which has a cross-sectional shape substantially similar to that of the container, an outer electrode insulating plate (11) which a mouth portion of the container contacts when the container is housed in the hollow of the outer electrode, an inner electrode (16) inserted from the mouth portion of the container, which is housed in the hollow of the outer electrode, into the interior thereof, a gas discharge means communicating with the hollow of the outer electrode and adapted to discharge the gas from the same hollow, a means for supplying a raw material gas to the interior of the container housed in the hollow of the outer electrode, and a high-frequency power source (14) connected to the outer electrode, the container being housed in the hollow of the outer electrode with the outer electrode insulated by the insulating member, the inner electrode being inserted into the container and grounded, the interior of the hollow of the outer electrode being evacuated, a raw material gas being supplied to the interior of the container housed in the same hollow, a carbon film coating operation being then carried out with a high-frequency wave applied to the outer electrode. <IMAGE>
Patent DK-0800381-T3 (DK)
Inventor: VARRELA JUHA
IPC: A61J17/00
Filed: 1995-10-04
Granted: 2004-08-30
Abstract: PCT No. PCT/FI95/00542 Sec. 371 Date Jun. 27, 1997 Sec. 102(e) Date Jun. 27, 1997 PCT Filed Oct. 4, 1995 PCT Pub. No. WO96/20687 PCT Pub. Date Jul. 11, 1996A baby pacifier includes an actual nipple part and a shield. The actual nipple part includes a piece made of elastic or resilient material that is adapted to be held in the baby's mouth at a location between the middle section of the palate and the tongue, and on which piece the baby exerts suction by movements of the jaws and the tongue. The actual nipple part is shaped so that a vertical cross-sectional profile, viewed in a vertical cross-sectional plane of the buccal cavity, is elongated with protrusions directed from the a middle part of the vertical cross-sectional profile to both sides extending to the alveolar ridges and/or the teeth of the baby's upper jaw. The protrusions are shaped so as to create from the baby's sucking motion principally lateral outward pressure on the inside of the alveolar ridges and deciduous teeth of the baby when the actual nipple part is held in a baby's mouth. The vertical cross-sectional profile of the actual nipple part is slightly V-shaped or the upper edge of the cross-sectional profile has a downwards curvature so that the actual nipple part exerts essentially no pressure on the middle section of the palate.
Patent DK-0806960-T3 (DK)
Inventor: MARENUS KENNETH
IPC: A61K8/00
Filed: 1995-10-30
Granted: 2003-04-22
Abstract: The present invention relates to cartilage extracts and to a method of producing the same. Shark cartilage extracts having anti-angiogenic, direct anti-tumor proliferating, anti-inflammatory and anti-collagenolytic activities have been obtained by an improved process. The process comprises the steps of obtaining a homogenate of cartilage in an aqueous solution, this homogenate being centrifuged and further fractionated to obtain a total extract having molecules of a molecular weight comprised between 0 to 500 KDa. The composition of the liquid extract has then been investigated by different ways. Further fractionation of this extract led to the preliminary characterization of some of its active components. Due to the multiplicity of biological activities of the total liquid extract, it can be used for treating numerous diseases or conditions such as those having components selected from the group consisting of tumor proliferation, angiogenesis, inflammation and collagenolysis. This extract has no offensive effect on normal body functions. Therefore, this shark cartilage extract has a very promising therapeutic value. The process for the obtention of cartilage extracts is simple and efficient. The unexpectedly valuable products obtained by this process are therefore an indication of a new and non-obvious process.
Patent DK-0799206-T3 (DK)
Inventor: BREU VOLKER
IPC: C07D405/12
Filed: 1995-12-04
Granted: 2003-01-27
Abstract: Compounds of formula I wherein R1 signifies phenyl, substituted phenyl or heterocyclyl; R2 signifies phenyl or substituted phenyl; R3 signifies hydrogen, lower-alkyl, cyano, carboxy, esterified carboxy, phenyl, substituted phenyl, heterocyclyl or a residue -CONR5R6 or -NR5COR7; R4 signifies hydrogen or lower-alkyl; R5 signifies hydrogen or a residue R7, and R6 signifies -(CH2)mR7; or R5 and R6 together with the N atom associated with them signify a heterocyclic residue; R7 signifies phenyl, substituted phenyl, cycloalkyl, heterocyclyl, lower-alkyl, cyano-lower-alkyl, hydroxy-lower-alkyl, di-lower-alkylamino-lower-alkyl, carboxy-lower-alkyl, lower-alkoxycarbonyl-lower-alkyl, lower-alkoxycarbonylamino-lower-alkyl or phenyl-lower-alkoxycarbonyl; Ra signifies hydrogen, lower-alkyl or hydroxy; Rb signifies hydrogen or lower-alkyl; Z signifies hydroxy, amino or a residue -OR8, -OC(O)NHR8, -OC(O)OR8, -NHC(O)NHR8 or -NHC(O)OR8; R8 signifies heterocyclyl, phenyl, substituted phenyl or lower-alkyl; A and Y each independently signify oxygen or sulphur, X signifies nitrogen or CH; m signifies 0, 1 or 2; and n signifies 0, 1 or 2; and pharmaceutically usable salts thereof are inhibitors of endothelin receptors. They can therefore be used for the treatment of disorders which are associated with endothelin activities, especially circulatory disorders such as hypertension, ischaemia, vasospasms and angina pectoris.
Patent DK-0815758-T3 (DK)
Inventor: BOUCHOMS JEAN-FRANCOIS
IPC: A43B13/22
Filed: 1996-11-04
Granted: 1998-05-25
Abstract: The inner surface of the sole facing the insole, and the outer surface facing away from the insole or underside (21) have protuberances (23) and a rim enclosing the surface of the sole. The protuberances form a rectangular mesh and run across the longitudinal direction or axis in the form of discontinuous arms of the sole. At least one lengthwise ridge (27,29) on the underside of the sole, parallel with the outline of the sole, is positioned at least along the outside (25) of the sole and is spaced apart from the outline by an amount less than half the width of the sole near the heel (9). A sickle-shaped reinforcement part between the ball of the foot (11) and heel parts extends outwards from the inside of the sole.
Patent DK-0770812-T3 (DK)
Inventor: KITTSON MARK
IPC: B29C53/38
Filed: 1996-10-25
Granted: 2002-03-18
Abstract: Conduit liners (100) and methods for their construction and use are provided. The liners include a first flexible layer (10) mechanically bonded to at least one glass-containing layer (20) and folded to form a tubular laminate. The laminate can be penetrable by resinous liquid capable of setting the form of substantially continuous matrix within the laminate following the expansion of the laminate within a conduit. In preferred versions of the liner, multiple glass layers are provided on the inner and outer diameter of the construction with a polyester core so as to meet minimum thickness requirements for vibration resistance under American in situ pipe vibration resistance codes.  <IMAGE>